- Exchange: Istanbul
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Deva Holding AS
+ Add to WatchlistDEVA:TI
2.40000 TRY 0.06000 2.56%As of 10:39:33 ET on 05/17/2013.
Snapshot for Deva Holding AS (DEVA)
| Open: | 2.36000 | Day's Range: | 2.35000 - 2.40000 | Volume: | 1,367,119 |
|---|---|---|---|---|---|
| Previous Close: | 2.34000 | 52wk Range: | 1.97000 - 2.43000 | 1-Yr Rtn: | +4.80% |
Key Statistics for DEVA
| Current P/E Ratio (ttm) | 12.8522 |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. XU100 | 0.9461 |
| Earnings Per Share (ttm) | 0.1867 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M TRY) | 480.00 |
| Shares Outstanding (M) | 200.00 |
| 30 Day Average Volume | 642,716 |
| Price/Book (mrq) | 1.2680 |
| Price/Sale (ttm) | 1.1058 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (TRY) | - |
| Last Dividend | 07/21/2009 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/23/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DEVA
Company Profile & Key Executives for DEVA
Deva Holding A.S. manufactures medicines, household products, cosmetics, and chemicals. The Company produces both human and animal pharmaceuticals.
| Philipp Daniel HaasChairman/CEO | Carlo DurrerChief Operating Officer |
| Tuba Koseoglu OkcuOrganizational Development Director | Sirin Deha EbrahimiBus Dev Reg Affairs & R&D Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DEVA News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page